434 related articles for article (PubMed ID: 11111232)
41. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
Glaspy JA; Shpall EJ; LeMaistre CF; Briddell RA; Menchaca DM; Turner SA; Lill M; Chap L; Jones R; Wiers MD; Sheridan WP; McNiece IK
Blood; 1997 Oct; 90(8):2939-51. PubMed ID: 9376574
[TBL] [Abstract][Full Text] [Related]
42. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
[TBL] [Abstract][Full Text] [Related]
43. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
44. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
[TBL] [Abstract][Full Text] [Related]
45. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation.
Heuft HG; Dubiel M; Kingreen D; Oertel J; De Reys S; Rick O; Serke S; Schwella N
Vox Sang; 2000; 79(2):94-9. PubMed ID: 11054047
[TBL] [Abstract][Full Text] [Related]
46. Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.
André M; Baudoux E; Bron D; Canon JL; D'Hondt V; Fassotte MF; D'Hondt L; Fillet G; Humblet Y; Jerusalem G; Vermeulen P; Symann M; Beguin Y
Transfusion; 2003 Jan; 43(1):50-7. PubMed ID: 12519430
[TBL] [Abstract][Full Text] [Related]
47. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome.
Lazarus HM; Pecora AL; Shea TC; Koç ON; White JM; Gabriel DA; Cooper BW; Gerson SL; Krieger M; Sing AP
Bone Marrow Transplant; 2000 Mar; 25(5):559-66. PubMed ID: 10713636
[TBL] [Abstract][Full Text] [Related]
48. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
49. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
50. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution.
Schwella N; Siegert W; Beyer J; Rick O; Zingsem J; Eckstein R; Serke S; Huhn D
Ann Hematol; 1995 Nov; 71(5):227-34. PubMed ID: 7492625
[TBL] [Abstract][Full Text] [Related]
51. Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.
Elayan MM; Horowitz JG; Magraner JM; Shaughnessy PJ; Bachier C
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1921-5. PubMed ID: 26033279
[TBL] [Abstract][Full Text] [Related]
52. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.
Grigg AP; Roberts AW; Raunow H; Houghton S; Layton JE; Boyd AW; McGrath KM; Maher D
Blood; 1995 Dec; 86(12):4437-45. PubMed ID: 8541532
[TBL] [Abstract][Full Text] [Related]
53. Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
Bolwell BJ; Goormastic M; Andresen S; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1997 Sep; 20(6):459-63. PubMed ID: 9313878
[TBL] [Abstract][Full Text] [Related]
54. Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation.
Engelhardt M; Bertz H; Wäsch R; Finke J
Ann Hematol; 2001 Apr; 80(4):201-8. PubMed ID: 11401085
[TBL] [Abstract][Full Text] [Related]
55. A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients.
Cesaro S; Tintori V; Nesi F; Schiavello E; Calore E; Dallorso S; Migliavacca M; Capolsini I; Desantis R; Caselli D; Fagioli F; Luksch R; Panizzolo I; Tridello G; Prete A
Transfusion; 2013 Jul; 53(7):1501-9. PubMed ID: 23034006
[TBL] [Abstract][Full Text] [Related]
56. Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors.
Chaisiripoomkere W; Jootar S; Ungkanont A
Asian Pac J Allergy Immunol; 2001 Sep; 19(3):183-90. PubMed ID: 11826913
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery.
Gündüz E; Demirel G; Bal C; Gulbas Z
Cytotherapy; 2010 Dec; 12(8):1006-12. PubMed ID: 20735165
[TBL] [Abstract][Full Text] [Related]
58. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.
Brown RA; Adkins D; Goodnough LT; Haug JS; Todd G; Wehde M; Hendricks D; Ehlenbeck C; Laub L; DiPersio J
J Clin Oncol; 1997 Sep; 15(9):3067-74. PubMed ID: 9294469
[TBL] [Abstract][Full Text] [Related]
59. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
[TBL] [Abstract][Full Text] [Related]
60. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.
van der Wall E; Richel DJ; Holtkamp MJ; Slaper-Cortenbach IC; van der Schoot CE; Dalesio O; Nooijen WJ; Schornagel JH; Rodenhuis S
Ann Oncol; 1994 Nov; 5(9):795-802. PubMed ID: 7531486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
